Ameliorating effect of anti-Alzheimer’s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental biology and medicine

• Publication date

  2017-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1535370217711440PMID 28534431PMCID PMC5529002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

  2015cited by this paper
• Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer’s disease

  2015cited by this paper
• Elevated HbA1c is Associated with Increased Risk of Incident Dementia in Primary Care Patients

  2015cited by this paper
• Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

  2015cited by this paper
• Magnesium and type 2 diabetes.

  2015cited by this paper
• Evaluating the Association between Diabetes, Cognitive Decline and Dementia

  2015cited by this paper
• Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

  2015cited by this paper
• Type 2 diabetes mellitus and Alzheimer's disease.

  2014cited by this paper
• Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions

  2014cited by this paper
• High Levels of HbA1c from T2DM Patients Positively Correlated with Increased of Oxidative Stress Biomarker and IL-6 Levels

  2014influential reference
• Impaired glycemia increases disease progression in mild cognitive impairment.

  2014cited by this paper
• Magnesium Protects Cognitive Functions and Synaptic Plasticity in Streptozotocin-Induced Sporadic Alzheimer’s Model

  2014influential reference
• The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital

  2014cited by this paper
• Structure modeling and dynamics driven mutation and phosphorylation analysis of Beta-amyloid peptides

  2014cited by this paper
• Dyslipidemia and the Risk of Alzheimer’s Disease

  2013cited by this paper
• Plasma Aβ: A Possible Missing Link Between Alzheimer Disease and Diabetes

  2013cited by this paper
• Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India

  2013cited by this paper
• Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease.

  2013cited by this paper
• Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2

  2013cited by this paper
• Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes

  2012cited by this paper
• Elevated Serum C-Reactive Protein Relates to Increased Cerebral Myoinositol Levels in Middle-Aged Adults

  2012cited by this paper
• Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer’s Disease

  2012cited by this paper
• Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

  2012cited by this paper
• Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway

  2012cited by this paper
• Inflammation and thrombosis in diabetes

  2011cited by this paper
• Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase‐1 expression and activity

  2011cited by this paper
• Cognitive function, dementia and type 2 diabetes mellitus in the elderly

  2011influential reference
• Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

  2011cited by this paper
• The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings.

  2010cited by this paper
• D-dimer antigen: current concepts and future prospects.

  2009influential reference
• Elevated plasma fibrin D‐dimer as a risk factor for vascular dementia: the Three‐City cohort study

  2009cited by this paper
• Oxidative Stress in Diabetes and Alzheimer's Disease

  2009cited by this paper
• Adiposity, Type 2 Diabetes, and Alzheimer's Disease

  2009cited by this paper
• Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice

  2009cited by this paper
• Defective insulin signaling pathway and increased glycogen synthase kinase‐3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin

  2008influential reference
• Biomarkers for Alzheimer's disease – Clinical needs and application

  2006cited by this paper
• C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease

  2005cited by this paper
• Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention

  2004cited by this paper
• An 18-year follow-up of overweight and risk of Alzheimer disease.

  2003cited by this paper
• Clinical review 124: Diabetic dyslipidemia: causes and consequences.

  2001cited by this paper
• Diabetic Dyslipidemia: Causes and Consequences

  2001cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• The physiological structure of human C-reactive protein and its complex with phosphocholine.

  1999cited by this paper
• Multicenter harmonization of common enzyme results by fresh patient-pool sera.

  1998cited by this paper
• [Indices of obesity derived from body weight and height].

  1995cited by this paper
• Measurement of Insulin Secretion in Type 2 Diabetes: Problems and Pitfalls

  1992cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Indices of obesity derived from body weight and height.

  1967cited by this paper
• Spectrophotometric determination of magnesium with 1-azo-2-hydroxy-3-(2.4-dimethylcarboxanilido)-naphtha- lene-1-(2-hydroxybenzene)

  1957cited by this paper

• The Comparison Between Dietary Vitamin A Deficiency and the CRP Level in Alzheimer's Disease in Patients with Type 2 Diabetes: A Case-Control Study.

  2025cites this paper
• Magnesium (Mg) and Neurodegeneration: A Comprehensive Overview of Studies on Mg Levels in Biological Specimens in Humans Affected Some Neurodegenerative Disorders with an Update on Therapy and Clinical Trials Supplemented with Selected Animal Studies

  2024cites this paper
• True or False? Alzheimer's disease is Type 3 Diabetes: Evidences from Bench to Bedside.

  2024cites this paper
• Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system

  2024cites this paper
• Metabolic Profile of Alzheimer’s Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?

  2023cites this paper
• Correlation between inflammatory biomarkers, cognitive function and glycemic and lipid profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

  2023cites this paper
• Diabetes mellitus and energy dysmetabolism in Alzheimer's disease: Understanding the relationships and potential therapeutic targets.

  2023cites this paper
• A Novel Strategy for Alzheimer’s Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora

  2022cites this paper
• Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis

  2022cites this paper
• Effects of Combining Biofactors on Bioenergetic Parameters, Aβ Levels and Survival in Alzheimer Model Organisms

  2022influential citation
• Nutritional intervention for diabetes mellitus with Alzheimer's disease

  2022cites this paper
• Up-regulation thioredoxin contributes to inhibite diabetic hearing impairment

  2021cites this paper
• Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; A systematic review and meta-analysis.

  2021cites this paper
• Metabolic Syndrome: Is It Time to Add the Central Nervous System?

  2021cites this paper
• [Different types of cognitive rehabilitation in patients with type 2 diabetes].

  2019cites this paper
• The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia

  2019cites this paper
• Elevated Plasma Level of D-dimer Predicts the High Risk of Early Cognitive Impairment in Type 2 Diabetic Patients as Carotid Artery Plaques become Vulnerable or Get Aggravated.

  2019cites this paper
• Exploring the Association between Alzheimer’s Disease, Oral Health, Microbial Endocrinology and Nutrition

  2017cites this paper